Drug product
Lisinopril Tablets USP, 30 mg, 100-count bottle, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Baltimore, Maryland 21202, NDC 68180-982-01
D-1079-2020
Product summary
- Event
- Event 85355
- Status
- Terminated
- Classification
- Class II
- Quantity
- 25,944 bottles
- Official record key
drug-enforcement:D-1079-2020
Official wording
Reason: Presence of Foreign Tablet/ Capsule: Product complaint received indicating mix-up of one lisinopril 5mg tablet inside of a 30 mg, 100-count bottle of Lisinopril Tablets.
Code information: Lot #: Q900580, Exp 9/2021
Distribution pattern: U.S.A. Nationwide
Derived failure modes
-
Foreign material or chemical contamination
Foreign Tablet